| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Meeting Reports |
1 Division of Gastroenterology, Departments of Medicine and Cancer Biology, Vanderbilt University School of Medicine; 2 Department of Veterans Affairs Medical Center, Nashville, Tennessee; and 3 Tumor Biology and Metastasis Branch, Division of Cancer Biology, National Cancer Institute, NIH, Bethesda, Maryland
Requests for reprints: Richard M. Peek, Jr., Division of Gastroenterology, Department of Medicine, Vanderbilt University School of Medicine, 1161 21st Avenue South, C-2104 Medical Center North, Nashville, TN 37232-2279. Phone: 615-322-5200; Fax: 615-343-6229; E-mail: richard.peek{at}vanderbilt.edu.
The Inflammation and Cancer Think Tank Meeting was organized by the National Cancer Institute with the purpose of identifying research advances, gaps, and opportunities for the study and clinical application of the role of inflammation on tumorigenesis. The format of this meeting consisted of brief presentations that focused on concepts, with extensive discussion periods to allow participants to identify issues and barriers limiting progress in this area. The strong relationship between inflammation and cancer in the gastrointestinal tract prompted several presentations that were focused on carcinogenesis within this organ system; however, many of the same immune mediators that influence esophageal, gastric, and colorectal carcinoma were also shown to influence inflammation-related malignancies at other anatomic sites. This article summarizes the findings of this Think Tank Meeting, which highlight the intimate relationship between malignant cells and their inflammatory microenvironment and specifically address opportunities to manipulate the host immune response and therefore intervene at different points along the tumorigenic cascade.
This article has been cited by other articles:
![]() |
T. L. Phung, G. Eyiah-Mensah, R. K. O'Donnell, R. Bieniek, S. Shechter, K. Walsh, C. Kuperwasser, and L. E. Benjamin Endothelial Akt Signaling Is Rate-Limiting for Rapamycin Inhibition of Mouse Mammary Tumor Progression Cancer Res., June 1, 2007; 67(11): 5070 - 5075. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wolnicka-Glubisz, J. Damsker, S. Constant, S. Corn, E. De Fabo, and F. Noonan Deficient inflammatory response to UV radiation in neonatal mice J. Leukoc. Biol., June 1, 2007; 81(6): 1352 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Loh, V. J. Torres, and T. L. Cover Regulation of Helicobacter pylori cagA Expression in Response to Salt Cancer Res., May 15, 2007; 67(10): 4709 - 4715. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liao, D. N. Seril, A. L. Yang, G. G. Lu, and G.-Y. Yang Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds Carcinogenesis, February 1, 2007; 28(2): 446 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, K. L. O'Connor, X. Cheng, F. C. Mei, T. Uchida, C. M. Townsend Jr, and B. M. Evers Cyclic Adenosine 5'-Monophosphate-Stimulated Neurotensin Secretion Is Mediated through Rap1 Downstream of both Epac and Protein Kinase A Signaling Pathways Mol. Endocrinol., January 1, 2007; 21(1): 159 - 171. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |